Navigation Links
Quark Pharmaceuticals Expands International Patent Protection for Compounds Targeting the RTP801 Gene
Date:10/26/2009

of siRNA to other target tissues including the eye, ear, lung, spinal cord and brain.

In addition to PF-4523655, Quark's current clinical pipeline includes QPI-1002, the first systemically administered siRNA drug in human clinical trials, developed by Quark for the prevention of acute kidney injury (AKI) following major cardiovascular surgery and the prophylaxis of delayed graft function after kidney transplantation. Quark has licenses from Silence Therapeutics and from Alnylam Pharmaceuticals for the structure of these products.

QPI-1007, a siRNA that utilizes a proprietary structure developed by Quark, is being evaluated in advanced IND-enabling preclinical studies as a neuroprotective agent in eye diseases. In addition, Quark has a broad pipeline of siRNA drug candidates based on novel structures developed internally. The Company expects to utilize the structures to develop additional RNAi drug candidates.

Quark is headquartered in Fremont, California and operates research and development facilities in Boulder, Colorado and Ness-Ziona, Israel. Additional information is available at www.quarkpharma.com. 

    Quark Pharmaceuticals, Inc.         The Ruth Group (investors / media)
    Juliana Friedman                    Sara Ephraim / Janine McCargo
    +972 89 30 5111                     (646) 536-7002 / 7033
    jfriedman@quarkpharma.com           sephraim@theruthgroup.com
                                        jmccargo@theruthgroup.com

SOURCE Quark Pharmaceuticals, Inc.


'/>"/>
SOURCE Quark Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
2. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
3. Quark Pharmaceuticals Files Patent Application Covering Novel Chemical Modifications to its RNAi Molecules
4. Quark Pharmaceuticals Appoints New Chief Medical Officer
5. Quark Pharmaceuticals Signs Collaboration Agreement With University of Michigan for Development of Proprietary SiRNA Compounds for Noise-Induced Hearing Loss
6. Quark Pharmaceuticals, Inc. Announces First Systemic siRNA Dosing in Humans
7. Quark Pharmaceuticals Announces First Patient Dosing by Pfizer in Phase II Trial of RNAi Therapy in Diabetic Macular Edema
8. Silence Therapeutics to Receive $1.9m Milestone Payment as Pfizer and Quark Commence Phase II Trial
9. Quark Pharmaceuticals Announces First RNAi Drug Candidate Having a Novel, Proprietary Structure Covered by Quark Intellectual Property
10. Quark Pharmaceuticals Announces Publication of Study on Use of siRNA against Proprietary Target for Inhibiting Tumor Growth and Sensitization of Cancer Cells to Chemotherapy
11. Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... YORK , May 17, 2013 /PRNewswire-iReach/ -- United ... Advanced Cardiac Life Support (ACLS), Pediatric Advanced Life Support ... free PALS, BLS and ACLS online course ... manuals, people simply need to build an account with ... materials for these programs, United Medical Education is setting ...
(Date:5/17/2013)... PONCE , Puerto Rico , May ... southern, central and western Puerto Rico , ... , PR) Center has improved its radiation therapy capabilities with ... in Puerto Rico . Versa HD offers ... wide range of tumors throughout the body, while also enabling ...
(Date:5/17/2013)...  Sanofi (EURONEXT: SAN and NYSE: SNY ) ... , examining the selective JAK2 inhibitor SAR302503 for ... groups. The primary endpoint assessed the proportion of patients ... reported in previous trials, the most common adverse events ... be presented at an upcoming medical congress. ...
Breaking Medicine Technology:ACLS Online Course Manuals are Now Available at No Cost through United Medical Education 2Puerto Rico's Caribbean Imaging and Radiation Therapy Center Orders Elekta's New Versa HD System for Treatment of Cancer Patients 2Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 2Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 3Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 4Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 5Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 6
... Sept. 12 Alfacell Corporation,(Nasdaq: ACEL ) ... events,(patient deaths) have occurred in the Phase IIIb ... treatment of patients with unresectable,malignant mesothelioma. The number ... that total events in the study had reached ...
... in the Sept. 12 Issue of the Journal of the American Medical ... ... treat type 2,diabetes has been found to reduce the risk of death, heart ... diabetes, according to a Cleveland Clinic study. The study published in the ...
Cached Medicine Technology:Alfacell Updates Status of ONCONASE(R) Phase III Clinical Program 2Alfacell Updates Status of ONCONASE(R) Phase III Clinical Program 3Cleveland Clinic Study Shows the Diabetes Drug Pioglitazone Reduces Risk of Death, Heart Attack and Stroke, but Increases Risk of Heart Failure 2Cleveland Clinic Study Shows the Diabetes Drug Pioglitazone Reduces Risk of Death, Heart Attack and Stroke, but Increases Risk of Heart Failure 3
(Date:5/18/2013)... 2013 The topics that will be covered ... scrum roles, scrum meetings, scrum artifacts, and scrum simulation (optional). ... attending them. , These trainings are suitable for business analysts, ... for those who will be a part of the Scrum ... to explore Agile and Scrum, but are unsure of what ...
(Date:5/18/2013)... the the Stevens Johnson Syndrome Foundation, Stevens Johnson Syndrome (SJS), ... reaction usually to medicine (i). The first signs of ... blistering and large areas of dead skin. Some severe ... any time and seriously affect both children and adults. ... after he received kidney medicine which caused SJS (ii). ...
(Date:5/17/2013)... 18, 2013. Chronic trauma can inflict lasting damage to ... studies of people with post-traumatic stress disorder, or PTSD, ... in response to stressful tasks, such as recalling a ... threatening face. Now, researchers at NYU School of Medicine ... the brains of combat veterans with PTSD in the ...
(Date:5/17/2013)... Stryker hip lawsuit claims filed ... ABG II Modular-Neck Hip Stem recall continue to move forward ... According to court documents, a Case Management Conference was held ... which time the Court, among other things, set deadlines by ... submit Fact Sheets to Defendant and Liaison Counsel. The ...
(Date:5/17/2013)... Cleveland, OH (PRWEB) May 17, 2013 ... nosings are an eye-catching, resilient, slip-resistant renovation ... surface. Designed for new construction or staircase renovation ... and durability while providing a look to compliment ... industrial applications, but attractive enough for home stairs ...
Breaking Medicine News(10 mins):Health News:Affordable Scrum Trainings In Irvine by Conscires Agile Practices 2Health News:Affordable Scrum Trainings In Irvine by Conscires Agile Practices 3Health News:Injury Law Firm Announces New Informative Graphic on Common Medicines That Have Allegedly Been Linked to Stevens Johnson Syndrome 2Health News:For combat veterans suffering from post-traumatic stress disorder, 'fear circuitry' in the brain never rests 2Health News:Stryker Hip Lawsuit News: Bernstein Liebhard LLP Reports on Recent Case Management Conference in New Jersey Stryker Hip Recall Litigation 2Health News:Stryker Hip Lawsuit News: Bernstein Liebhard LLP Reports on Recent Case Management Conference in New Jersey Stryker Hip Recall Litigation 3Health News:New Bold Step Renovation Stair Treads and Nosings from Martinson-Nicholls Add Slip Resistance to Stairs 2
... , PARSIPPANY, N.J., July 15 ... continue to harbor illness-causing bacteria that can threaten families, according ... Council, sponsored by LYSOL((R)) brand products. Investigators swabbing for ... that, despite American home owners claiming to clean their kitchen ...
... deals Governor,s wage cuts for home care workers one more legal ... July 14 California home care recipients, care providers and their ... prevent the Schwarzenegger Administration from cutting In-Home Supportive Services (IHSS) wages. ... 9(th) Circuit Court of Appeals denied an emergency stay request by ...
... , WASHINGTON, July 14 Speaker ... Chairman George Miller, Chairman John Dingell and other senior House Democrats held ... today by the Tri-Committees on health care reform. , ... and closing statement. A transcript of the entire press conference will be ...
... , The Safe and Sound(R) Safety Management ... emergency responders better serve the autism community , ... MedicAlert Foundation International, the leader in emergency response medical information services, ... peace of mind through a new program, Medic Alert + Safe ...
... eating healthy, moderate activity are protective , TUESDAY, July ... that your genes don,t predispose you to dementia. , ... age, according to four new studies that were presented ... Vienna. , The findings echo other research suggesting that ...
... , MIAMI and SAN DIEGO, July 14 ... platform technology for the generation of fully human monoclonal antibodies, ... company with no active operations, have signed a merger agreement ... subsidiary of QuikByte. After the merger is completed, QuikByte ...
Cached Medicine News:Health News:American Hygiene Habits Getting Worse: International Study Reveals More Illness-Causing Germs Than Ever in American Kitchens 2Health News:American Hygiene Habits Getting Worse: International Study Reveals More Illness-Causing Germs Than Ever in American Kitchens 3Health News:American Hygiene Habits Getting Worse: International Study Reveals More Illness-Causing Germs Than Ever in American Kitchens 4Health News:Federal Appeals Court Protects California Home Care Pay 2Health News:Pelosi Remarks at Press Conference on Introduction of Health Care Legislation 2Health News:Pelosi Remarks at Press Conference on Introduction of Health Care Legislation 3Health News:MedicAlert Foundation and Autism Society Launch New Program to Safeguard Individuals and Families Living With Autism 2Health News:MedicAlert Foundation and Autism Society Launch New Program to Safeguard Individuals and Families Living With Autism 3Health News:Healthy Diet, Exercise Keeps Mind Sharp As You Age 2Health News:Healthy Diet, Exercise Keeps Mind Sharp As You Age 3Health News:QuikByte Software, Inc. and Sorrento Therapeutics, Inc. Announce Merger Agreement 2Health News:QuikByte Software, Inc. and Sorrento Therapeutics, Inc. Announce Merger Agreement 3
The Auto Suture™ ExtraHand™ balloon retractor is designed to be used during open surgery, gasless endoscopy, as well as endoscopy with gas insufflation....
Ethicon Endo-Surgery provides disposable handheld instruments that provide reliable, precise performance every time. Our handheld instruments come in 5mm and 10mm sizes....
... Auto Suture™ ENDO RETRACT™ ... (3) atraumatic fingers, has ... of gynecologic, general, urologic, ... for temporary retraction of ...
... RETRACT™ 12 mm instrument has application in ... and other endoscopic procedures for retracting internal ... , ,The ENDO PADDLE RETRACT™ instrument ... distal end of the instrument and is ...
Medicine Products: